TECHWIRE 30
(CIX: WRAL30)  1,095.48    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NQ: Apple)  95.18    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NY: Q)  67.46    (0 %)  Updated: 08:04 PM EDT, May 03 2016
(OP: BASFY)  78.54    (0 %)  Updated: 05:20 PM EDT, May 03 2016
(NQ: BCRX)  3.24    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NQ: BDSI)  2.99    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NQ: CEMP)  17.04    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NQ: Cisco)  26.86    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NQ: CREE)  23.57    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NQ: DARA)  0.88    (0 %)  Updated: 08:10 PM EST, Dec 04 2015
(NY: EMC)  26.16    (0 %)  Updated: 08:04 PM EDT, May 03 2016
(NQ: EXTR)  3.51    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NQ: Facebook)  117.43    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NY: GSK)  43.14    (0 %)  Updated: 08:04 PM EDT, May 03 2016
(NQ: Alphabet)  692.36    (0 %)  Updated: 08:10 PM EDT, May 03 2016
(NY: IBM)  144.13    (0 %)  Updated: 08:04 PM EDT, May 03 2016

Posts tagged “Biotech & Life Science”

Updated 8 minutes ago

Premium Lock Exclusive: What's next for health analytics startup Bivarus?

David Levin David Levin, the veteran Triangle entrepreneur who is CEO of analytics startup Bivarus, talks about what's next for the company which recently raised venture funding, made an acquisition in Hickory, and has big plans for the future. Plus. Bivarus is hiring. He also explains why Bivarus bought Jackson Group - in part for something called CAHPS.

Updated 6:46 a.m. today

Quintiles, IMS to merge, forming $17.6B firm; Street lukewarm to deal

Durham-based life science services giant Quintiles is merging with IMS Health Holdings in a deal forming a company worth some $17.6 billion. The merger was announced early Tuesday. Quintiles founder Dennis Gillings will lead the combined board but IMS shareholders will hold majority of stock. Wall Street, however, reacts negatively to the news.

Quintiles' headquarters       Quintiles' headquarters

Updated 6:42 a.m. today

Premium Lock CEOs' meeting leads to huge $17.6B Quintiles-IMS merger

The merger of Quintiles and IMS Health creating a $17 billion health services company announced Tuesday can be traced back to a meeting between the two CEOs last year. Quintiles' Tom Pike tells analysts the two firms discovered quickly how well they could work together, and the CEO of IMS says the collaboration has already delivered "major wins."

Tom Pike Tom Pike

Updated 1:27 p.m. yesterday

Premium Lock Analyst: Q-IMS merger could trigger more deals; why Street doesn't like Q deal

Tech mergers Tuesday's merger of Quintiles with IMS Health Services might trigger other CRO deals affecting the Triangle, says Chapel Hill-based analyst Andrew Schafer of Industry Standard Research. Also, Wall Street is giving the Q deal the thumbs down as shares tumble 8 percent. Why? Schafer explains. Plus, a Bloomberg columnist weighs in.

Updated 12:48 p.m. yesterday

Premium Lock Durham analytics firm Bivarus acquires Hickory consulting company

Bivarus, a startup focusing on patient experience anayltics that raised $2 million in March, has acquired a Hickory-based firm that provides healthcare measurement and consulting.

Bivarus offers real-time health analytics Bivarus offers real-time health analytics

9:40 a.m. yesterday

Premium Lock Quintiles merger Q&A: Local impact, why do the deal, more

Merger Any time companies merger, they talk about cost savings and "synergies." That often means layoffs with redundant services and more often being cut. So will there be an immediate impact in Durham at Quintiles' global headquarters? And why merge with IMS Health Services? WTW asks a Quintiles exec for details.

Updated 3:57 p.m. Monday

Premium Lock 'War on talent:' Hiring, layoffs, finding contractors headline news at INC

INC Research INC Research's latest earnings report reflects growth in earnings, revenue and hiring. But a separate SEC filing discloses 175 layoffs as part of a reorganization. More are coming. Company execs also say they are using more contractors, which often are more expensive than full-time employees. What's going on? CROs such as INC, and Quintiles are battling for a particular kind of talent. They are known as CRAs.

Updated 6:09 a.m. Monday

BASF: Layoffs expected to affect 106 jobs in RTP

BASF says its layoffs in Research Triangle Park are expected to affect "only 106 jobs," not as many as 190 as cited in a mass layoff filing with the state of North Carolina.

Inside BASF's RTP facility. Inside BASF's RTP facility.

Updated 6:01 a.m. Monday

'God particle' search; Parkinson's drug; Mayer $55M parachute; Ichan dumps Apple

Bulldog In today's Bulldog wrapup of technology and life science news: The search resumes for the "God particle" at CERN; the FDA approves a Parkinson's disease drug; Marissa Mayer gets $55 million severance package if ousted; and billionaire Carl Icahn sells his stake in Apple.

5:50 a.m. Monday

WTW news in review: Week of April 25, part one

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire for the week of April 25, part one of two.

5:45 a.m. Monday

WTW news in review: Week of April 25, part two

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire for the week of April 25, part two of two.

5:30 a.m. Monday

We want your news: Send WTW your info - and views

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

April 29

Bob Ingram renominated for troubled Valeant board

Valeant    Bob Ingram, a longtime Triangle pharmaceutical executive and investor, has been renominated to the board of directors at troubled Valeant Pharmaceuticals. He will be replaced as chairman by incoming CEO Joe Papa.

Updated April 29

RTP headlines: AgBiome opens new facility; NC leads in grid storage; PRA beats Street; MaxPoint reverse split

Triangle headlines In our latest wrapup of Triangle headlines: AgBiome moves into new headquarters in RTP; a North Carolina utility takes the lead in power grid storage; PRA Health Sciences earnings tops analysts expectations; and MaxPoint pulls off a reverse merger.

Updated April 29

Premium Lock Executive Q&A: Practichem CEO talks new funding, hiring plans, benefits of relocating to Triangle

Practichem, a biotechnology instrumentation and software startup based in Raleigh, is a company you may not have heard much about. Until Thursday. Landing $5 million in funding is generating buzz. In an exclusive Q&A, its founder and CEO talks about plans for the funding, hiring, sales, new products, and the benefits of moving to Raleigh from Wisconsin.

Nick DeMarco Nick DeMarco

Updated April 29

Startup pitches, David Price highlight First Flight Venture Center event

One of the most significant incubators of small businesses in North Carolina is celebrating National Small Business Week with a visit from its district's Congressman -- and hopefully, from you. Plus, there will be pitches by startups hoping to attract interest from investors.

First Flight Venture Center First Flight Venture Center

Updated April 29

Apple's medical apps; Sanofi offers $9B for SF firm; Comcast-DreamWorks deal; FTC hits Amazon

Bulldog Bulletin In today's Bulldog wrapup of technology and life science news: Apple unveils medical apps for iPhones; Sanofi badly wants to buy a San Francisco pharmaceutical firm; Comcast is buying DreamWorks; and the FTC wins court case over in-apps purchases made by children through Amazon.

Updated April 28

Premium Lock Biotech instrumentation startup Practichem lands $5M

Practichem, a biotechnology instrumentation and software startup based in Raleigh, raises $5 million from investors. The company plans to expand its staff in multiple areas as a result.

The Arista Slice The Arista Slice

April 28

Report: Bob Ingram leaving as Valeant chair; drug firm's prices under fire

Valeant, which acquired two Raleigh-based drug firms last year, is blasted for its pricing strategies in a U.S. Senate hearing on Wednesday. Meanwhile, The Wall Street Journal reports that veteran Triangle life science executive Bob Ingram is going to give up his post as board chairman.

Valeant under fire Valeant under fire

April 28

Pfizer will pay NC $45 million to settle Medicaid rebate shortfall

Pfizer A group of states including North Carolina settled with drug maker Pfizer on Wednesday to settle two lawsuits that alleged the company owed millions in rebates to Medicaid for heartburn and acid reflux medications.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith